Track 24: Global trends in Nosocomial and Healthcare Acquired Infections

The global hospital acquired infections testing market is poised to grow at a compound annual growth rate (CAGR) of around 19.1% over the next decade to reach approximately $2.75 billion by 2025.

The global market for selected healthcare-acquired infection (HAI) treatments was valued at nearly $15.2 billion in 2014. This market is expected to increase from nearly $17.1 billion in 2015 to $23 billion by 2020, with a compound annual growth rate (CAGR) of 6.1% from 2015 to 2020.
Estimated cost of treating resistant infections in U.S. Health care system is about $21 billion to $34 billion annually.

    Related Conference of Track 24: Global trends in Nosocomial and Healthcare Acquired Infections

    January 28-29, 2026

    24th World Congress on Nutrition and Food Chemistry

    Zurich, Switzerland
    April 02-03, 2026

    7th European Food Chemistry Congress

    Geneva, Switzerland
    May 25-26, 2026

    9th European Food Science Congress

    Paris, France
    May 25-26, 2026

    20th International Conference on Food Microbiology

    Zurich, Switzerland
    May 25-26, 2026

    35th World Conference on Food and Beverages

    Zurich, Switzerland
    October 08-09, 2026

    30th International Conference on Food and Nutrition

    Rome, Italy
    October 29-30, 2026

    5th International Conference on Agroecology and Organic farming

    Aix-en-Provence, France

    Track 24: Global trends in Nosocomial and Healthcare Acquired Infections Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in